🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Comparative Cohort Study of Premium Versus Economy Cabin Travel and Popliteal Vein Diameter After Long-Haul Flight After an Aesthetic Surgery

Recruitingn/aAges 18 Years - 65 YearsAllResearch Inc
NCT07810179 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective cohort study will compare popliteal vein diameter changes in international travelers who independently fly to Bogota in premium business/first class or economy class. Standardized bilateral ultrasound will be performed before flight, within 2 hours after arrival, and at 24 and 48 hours. The primary outcome is the adjusted between-group difference in change from preflight diameter to arrival. Travel behavior and venous-risk confounders will be measured prospectively.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 to 65 years. * Commercial flight to Bogota with at least 4 hours of total airborne time. * Prebooked premium business/first-class or economy-class seat documented before enrollment. * Standardized preflight ultrasound within 24 hours before departure. * Arrival, 24-hour, and 48-hour ultrasound completed before surgery. * Written informed consent. Exclusion Criteria: * Current or prior unprovoked deep venous thrombosis requiring therapeutic anticoagulation. * Therapeutic anticoagulation during the study window. * Current pregnancy. * Lower-extremity condition preventing standardized bilateral popliteal ultrasound. * Surgery, prolonged immobilization, or major intravenous fluid administration before completion of the 48-hour scan. * Use of cabin upgrade after baseline or inability to verify the actual cabin flown.
💊

What it tests

  • Premium Cabin Air Travel Exposure
  • Economy Cabin Air Travel Exposure
  • Standardized Bilateral Popliteal Vein Ultrasound
📍

Where

1 site
Clinica INO
Bogotá, Colombia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy